Highbridge Capital Management LLC Pacira Bio Sciences, Inc. Transaction History

Highbridge Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $1.38 Million - $1.99 Million	-50,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $3 Million - $4.64 Million	-100,000 Reduced 66.67%	50,000 $1.56 Million
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $1.68 Million - $2.47 Million	-52,700 Reduced 26.0%	150,000 $6.85 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $307,662 - $340,411	8,618 Added 4.44%	202,700 $7.61 Million
Q2 2017 Aug 14, 2017	BUY	N/A	194,082	194,082 $9.26 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.